Takeda Pharmaceutical (TAK) Depreciation & Amortization (CF) (2018 - 2026)
Takeda Pharmaceutical's Depreciation & Amortization (CF) came in at $1.02 billion for the quarter ended Jun 30, 2026, down 18.5% from $1.26 billion a year earlier and down 16.9% from the prior quarter.
Takeda Pharmaceutical (TAK) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Takeda Pharmaceutical reported Depreciation & Amortization (CF) of $7.92 billion, down 6.2% year-over-year; for the year ended Mar 31, 2026, it was $4.79 billion, down 4.2% from the prior year.
- Depreciation & Amortization (CF) carries a five-year compound annual growth rate of -1.9% (years ended Mar 2021 to Mar 2026).
- Going back by year, Depreciation & Amortization (CF) was $5 billion in the year ended Mar 31, 2025 (-1.0%), $5.05 billion in the year ended Mar 31, 2024 (+2.6%), $4.92 billion in the year ended Mar 31, 2023 (-5.3%) and $5.19 billion in the year ended Mar 31, 2022 (-1.6%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Depreciation & Amortization (CF) since the quarter ended Dec 31, 2018.
- Year-over-year, Depreciation & Amortization (CF) increased in two of the last eight quarters, with an average decline of 5.2%.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in the quarter ended Sep 30, 2023 (growth of 18.5%), and the weakest in the quarter ended Jun 30, 2026 (a decline of 18.5%).
- Business Quant data shows TAK's Depreciation & Amortization (CF) at $1.23 billion (quarter ended Mar 31, 2026), $1.24 billion (quarter ended Dec 31, 2025) and $4.42 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn | 1.02 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Bn |
| Mar 31, 2026 | 1.23 Bn |
| Dec 31, 2025 | 1.24 Bn |
| Sep 30, 2025 | 4.42 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.43 Bn |
| Dec 31, 2024 | 1.23 Bn |
| Sep 30, 2024 | 4.53 Bn |
| Jun 30, 2024 | 1.23 Bn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.27 Bn |
| Sep 30, 2023 | 4.68 Bn |
| Jun 30, 2023 | 1.25 Bn |
| Mar 31, 2023 | 1.36 Bn |
| Dec 31, 2022 | 1.25 Bn |
| Sep 30, 2022 | 3.95 Bn |
| Jun 30, 2022 | 1.22 Bn |
| Jun 30, 2021 | 1.31 Bn |
| Mar 31, 2021 | 1.32 Bn |
| Jun 30, 2020 | 1.32 Bn |
Takeda Pharmaceutical Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();